Medicare Payment Advisory Commission Nomination Letters, 63713 [E8-25358]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 208 / Monday, October 27, 2008 / Notices
mstockstill on PROD1PC66 with NOTICES
underlying analytics substantially,
increase the breadth and depth of their
public records data, and overcome the
resistance of many law enforcement
customers to switch to a product that
lacks the track record of effectively
serving the needs of the law
enforcement community in order to
seriously contend for the customers that
currently work with LexisNexis or
ChoicePoint. As a result, new entry or
fringe expansion sufficient to achieve a
significant market impact within two
years is unlikely.
IV. The Consent Agreement
The proposed Consent Agreement
effectively remedies the Proposed
Acquisition’s likely anticompetitive
effects in the market for electronic
public records services to law
enforcement customers. The proposed
Consent Agreement preserves
competition by requiring the divestiture
of assets related to ChoicePoint’s
AutoTrackXP and CLEAR electronic
public records services to Thomson
Reuters Legal Inc. (‘‘West’’) within
fifteen (15) days after the Proposed
Acquisition is consummated.
The Commission is satisfied that West
is a well-qualified acquirer of the
AutoTrackXP and CLEAR assets. West
has the resources, capabilities,
experience, and reputation to ensure
that it will be an effective competitor in
the market for electronic public records
services to law enforcement customers.
West, headquartered in Eagan,
Minnesota, is a subsidiary of Thomson
Reuters, one of the world’s leading
information service providers to the
legal and business community. West
already has a large and experienced
sales force with existing relationships
with many law enforcement agencies
which use West’s legal research
services. With the divested assets, West
will be particularly well-situated to
replicate ChoicePoint’s success and
compete against the combined firm
immediately after the Proposed
Acquisition.
The proposed Consent Agreement
contains several provisions designed to
ensure that the divestiture of the
AutoTrackXP and CLEAR assets to West
is successful. First, the proposed
Consent Agreement requires Reed
Elsevier to provide various transitional
services such as customer service,
billing support, and database and
network maintenance for up to two
years to enable West to compete against
Reed Elsevier immediately following the
divestiture. Second, the proposed
Consent Agreement ensures that Reed
Elsevier will maintain the viability and
marketability of the AutoTrackXP and
VerDate Aug<31>2005
17:13 Oct 24, 2008
Jkt 217001
CLEAR assets prior to the divestiture.
Finally, the proposed Consent
Agreement allows the Commission to
appoint an Interim Monitor to ensure
that Reed Elsevier fulfills all of its
obligations related to the divestiture of
the assets.
In order to ensure that the
Commission remains informed about
the status of the AutoTrackXP and
CLEAR assets pending divestiture, and
about the efforts being made to
accomplish the divestiture, the
proposed Consent Agreement requires
Reed Elsevier to file periodic reports
with the Commission until the
divestiture is accomplished.
The purpose of this analysis is to
facilitate public comment on the
proposed Consent Agreement, and it is
not intended to constitute an official
interpretation of the proposed Consent
Agreement or to modify its terms in any
way.
By direction of the Commission.
Donald S. Clark
Secretary
[FR Doc. E8–25400 Filed 10–24–08: 8:45 am]
BILLING CODE 6750–01–S
GOVERNMENT ACCOUNTABILITY
OFFICE
Medicare Payment Advisory
Commission Nomination Letters
Government Accountability
Office (GAO).
AGENCY:
ACTION:
Notice on letters of nomination.
SUMMARY: The Balanced Budget Act of
1997 established the Medicare Payment
Advisory Commission (MedPAC) and
gave the Comptroller General
responsibility for appointing its
members. For appointments to MedPAC
that will be effective May 1, 2009, I am
announcing the following: Letters of
nomination should be submitted
between January 1 and March 31, 2009,
to ensure adequate opportunity for
review and consideration of nominees
prior to the appointment of new
members.
ADDRESSES:
GAO: 441 G Street, NW., Washington,
DC 20548.
MedPAC: 601 New Jersey Avenue, NW.,
Suite 9000, Washington, DC 20001.
FOR FURTHER INFORMATION CONTACT:
GAO: Office of Public Affairs, (202)
512–4800.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
63713
Authority: 42 U.S.C. 1395b–6.
Gene L. Dodaro,
Acting Comptroller General of the United
States.
[FR Doc. E8–25358 Filed 10–24–08; 8:45 am]
BILLING CODE 1610–02–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Public Meeting of the President’s
Council on Bioethics
Department of Health and
Human Services, Office of Public Health
and Science, The President’s Council on
Bioethics.
ACTION: Notice.
AGENCY:
SUMMARY: The President’s Council on
Bioethics (Edmund D. Pellegrino, MD,
Chairman) will hold its thirty-fifth
meeting, at which it will discuss three
topics: exercises of conscience in the
practice of the health professions, the
problem of medical futility, and the
future of public bioethics and national
bioethics commissions in the United
States. Subjects discussed at past
Council meetings (although not on the
agenda for the November 2008 meeting)
include: therapeutic and reproductive
cloning, assisted reproduction,
reproductive genetics, neuroscience,
aging retardation, organ transplantation,
personalized medicine, standards for
the determination of death, children and
bioethics, and lifespan-extension among
others. Publications issued by the
Council to date include: Human Cloning
and Human Dignity: An Ethical Inquiry
(July 2002); Beyond Therapy:
Biotechnology and the Pursuit of
Happiness (October 2003); Being
Human: Readings from the President’s
Council on Bioethics (December 2003);
Monitoring Stem Cell Research (January
2004), Reproduction and Responsibility:
The Regulation of New Biotechnologies
(March 2004), Alternative Sources of
Human Pluripotent Stem Cells: A White
Paper (May 2005), Taking Care: Ethical
Caregiving in Our Aging Society
(September 2005), and Human Dignity
and Bioethics: Essays Commissioned by
the President’s Council on Bioethics
(March 2008). Reports are forthcoming
on four topics: controversies in the
determination of death; organ donation,
procurement, allocation, and
transplantation; newborn screening; and
medical care and the common good.
DATES: The meeting will take place
Thursday, November 20, 2008, from 9
a.m. to 5 p.m., ET; and Friday,
November 21, 2008, from 9 a.m. to
noon, ET.
E:\FR\FM\27OCN1.SGM
27OCN1
]]>Agencies
[Federal Register Volume 73, Number 208 (Monday, October 27, 2008)]
[Notices]
[Page 63713]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-25358]
=======================================================================
-----------------------------------------------------------------------
GOVERNMENT ACCOUNTABILITY OFFICE
Medicare Payment Advisory Commission Nomination Letters
AGENCY: Government Accountability Office (GAO).
ACTION: Notice on letters of nomination.
-----------------------------------------------------------------------
SUMMARY: The Balanced Budget Act of 1997 established the Medicare
Payment Advisory Commission (MedPAC) and gave the Comptroller General
responsibility for appointing its members. For appointments to MedPAC
that will be effective May 1, 2009, I am announcing the following:
Letters of nomination should be submitted between January 1 and March
31, 2009, to ensure adequate opportunity for review and consideration
of nominees prior to the appointment of new members.
ADDRESSES:
GAO: 441 G Street, NW., Washington, DC 20548.
MedPAC: 601 New Jersey Avenue, NW., Suite 9000, Washington, DC 20001.
FOR FURTHER INFORMATION CONTACT: GAO: Office of Public Affairs, (202)
512-4800.
Authority: 42 U.S.C. 1395b-6.
Gene L. Dodaro,
Acting Comptroller General of the United States.
[FR Doc. E8-25358 Filed 10-24-08; 8:45 am]
BILLING CODE 1610-02-M
